肥胖对成人哮喘患者气道及全身炎症的影响:系统综述与荟萃分析
该系统综述与荟萃分析纳入40项研究,比较肥胖与非肥胖成人哮喘患者的气道炎症、全身炎症及脂肪因子。结果显示肥胖者痰中性粒细胞百分比更高、血中性粒细胞计数更高、支气管黏膜下嗜酸性粒细胞计数及痰IL-5更高,而呼出气一氧化氮更低;血CRP、IL-6和瘦素也更高。提示肥胖哮喘患者存在不同的炎症模式。
要点
- 肥胖成人哮喘患者痰中性粒细胞百分比更高,血中性粒细胞计数也更高。
- 肥胖者支气管黏膜下嗜酸性粒细胞计数和痰IL-5更高,但痰嗜酸性粒细胞百分比无差异。
- 肥胖者呼出气一氧化氮更低,血CRP、IL-6和瘦素更高。
核心结论
- 肥胖哮喘患者与非肥胖哮喘患者相比存在不同的炎症模式。
- 需要机制性研究探讨肥胖哮喘患者的炎症模式及其临床相关性。
研究设计与样本
- 系统综述与随机效应荟萃分析,检索Medline、Embase、CINAHL、Scopus和Current Contents至2021年8月11日。
- 纳入40项报告肥胖与非肥胖成人哮喘患者气道炎症、全身炎症和/或脂肪因子指标的研究。
- 采用I2统计量评估异质性,漏斗图评估发表偏倚。
主要发现
- 痰中性粒细胞百分比在肥胖者中高5.0%(均数差=5.0%,95%CI:1.2至8.9,n=2297,p=0.01,I2=42%)。
- 血中性粒细胞计数在肥胖者中也更高。
- 痰嗜酸性粒细胞百分比无差异;支气管黏膜下嗜酸性粒细胞计数(标准化均数差=0.58,95%CI=0.25至0.91,p<0.001,n=181,I2=0%)和痰IL-5(标准化均数差=0.46,95%CI=0.17至0.75,p<0.002,n=198,I2=0%)在肥胖者中更高。
- 呼出气一氧化氮在肥胖者中低4.5 ppb(均数差=-4.5 ppb,95%CI=-7.1 ppb至-1.8 ppb,p<0.001,n=2601,I2=40%)。
- 血C反应蛋白、IL-6和瘦素在肥胖者中更高。
临床怎么用
- 临床评估肥胖成人哮喘患者时,应认识到其炎症模式可能以中性粒细胞及某些嗜酸性粒细胞标志物升高为特征,而非单纯依赖呼出气一氧化氮。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Obesity is associated with more severe asthma, however, the mechanisms responsible are poorly understood. Obesity is also associated with low-grade systemic inflammation; it is possible that this inflammation extends to the airways of adults with asthma, contributing to worse asthma outcomes. Accordingly, the aim of this review was to examine whether obesity is associated with increased airway and systemic inflammation and adipokines, in adults with asthma. METHODS: Medline, Embase, CINAHL, Scopus and Current Contents were searched till 11 August 2021. Studies reporting measures of airway inflammation, systemic inflammation and/or adipokines in obese versus non-obese adults with asthma were assessed. We conducted random effects meta-analyses. We assessed heterogeneity using the I2 statistic and publication bias using funnel plots. RESULTS: We included 40 studies in the meta-analysis. Sputum neutrophils were 5% higher in obese versus non-obese asthmatics (mean difference (MD)=5.0%, 95% CI: 1.2 to 8.9, n=2297, p=0.01, I2=42%). Blood neutrophil count was also higher in obesity. There was no difference in sputum %eosinophils; however, bronchial submucosal eosinophil count (standardised mean difference (SMD)=0.58, 95% CI=0.25 to 0.91, p<0.001, n=181, I2=0%) and sputum interleukin 5 (IL-5) (SMD=0.46, 95% CI=0.17 to 0.75, p<0.002, n=198, I2=0%) were higher in obesity. Conversely, fractional exhaled nitric oxide was 4.5 ppb lower in obesity (MD=-4.5 ppb, 95% CI=-7.1 ppb to -1.8 ppb, p<0.001, n=2601, I2=40%). Blood C reactive protein, IL-6 and leptin were also higher in obesity. CONCLUSIONS: Obese asthmatics have a different pattern of inflammation to non-obese asthmatics. Mechanistic studies examining the pattern of inflammation in obese asthmatics are warranted. Studies should also investigate the clinical relevance of this altered inflammatory response. PROSPERO REGISTERATION NUMBER: CRD42021254525.
引用
- Scott HA, Ng SH, McLoughlin RF, et al. Effect of obesity on airway and systemic inflammation in adults with asthma: a systematic review and meta-analysis. Thorax. 2023. PMID: 36948588. doi:10.1136/thorax-2022-219268
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。